November 17-18, 2022
2-Day Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CETKey Sessions
Pawan Gupta
Panel: What are the Current Barriers for Success?
Stempeutics, India
Anna Gosiewska
Therapeutic Potential of Human Placenta Derived Adherent Cells
Celularity Inc., USA
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 - November 17th - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Topics
Day 1 - November 17th - ET (Eastern Time, GMT-05:00)
search
Topics
Showing 1 of 1 Streams
Challenges and Opportunities for MSCs
8:00am - 8:05am
Welcoming Remarks
- Patrick Murphy - Digital Events Conference Producer, Informa Connect, UK
8:05am - 8:50am
Panel: What are the Current Barriers for Success?
- Pawan Gupta - Senior Vice President Medical Affairs, Stempeutics, India
- Nitsan Halvey - Chief Medical Officer, Pluri, Israel
- Robert W. Mays - Executive Vice President, Regenerative Medicine and Neuroscience Programs, Athersys, USA
8:50am - 9:20am
MSCs for the Treatment of Multiple Sclerosis
- Dimitrios Karussis - Head, MS Centre and Unit of Neuroimmunology and cell therapies, Department of Neurology, Hadassah Hospital, Israel
9:20am - 9:50am
Gene Edited and Engineered MSC for Brain Tumors: From Bench to Bedside
- Khalid Shah - Professor/Vice Chair of Research, Neurosurgery/Director, Center for Stem Cell & Translational Immunotherapy, Brigham and Women's Hospital/Harvard Medical School Principal Faculty/Harvard Stem Cell Institute, USA
9:50am - 10:20am
Break and Networking
10:20am - 10:50am
MSC-Based Cell Therapy for COVID ARDS: Update on Progress and Challenges
- Daniel Weiss - Professor of Medicine, Pulmonary Medicine, Department of Medicine, University of Vermont, USA
10:50am - 11:20am
Reprogramming Host Immunity with MSCs
- Anthony Filiano - Assistant Professor in Neurosurgery, Duke University, USA
11:20am - 11:50am
Therapeutic Potential of Human Placenta Derived Adherent Cells
- Anna Gosiewska - Vice President, R&D, Degenerative Diseases, Celularity Inc., USA
11:50am - 12:20pm
Break and Networking
12:20pm - 12:50pm
Drug Delivery and MSCs: Controlling Dose Exposure to MSCs
- Biju Parekkadan - Associate Professor, Biomedical Engineering, Rutgers University, USA
12:50pm - 1:20pm
Genetically Modified MSCs: A Promising Tool for Therapeutics
- Robert Buchanan - CEO, Ambulero Inc., USA
- Zhao-Jun Liu - Professor & Director of Vascular Research Laboratory at Department of Surgery and Chief Scientific Officer, University of Miami Miller School of Medicine and Ambulero Inc., USA
1:20pm - 1:50pm
Pre-Conditioning Approaches to Improve MSC-Based Therapies
- Fernando A. Fierro - Associate Adjunct Professor, UC Davis School of Medicine, USA
Filter
Topics